HCPCS Range Genetic Testing

• 1 Genetic testing for amyotrophic lateral sclerosis (ALS) ( S3800 )

• 2 DNA analysis for germline mutations of the RET proto-oncogene for susceptibility to multiple endocrine neoplasia type 2 ( S3840 )

• 3 Genetic testing for retinoblastoma ( S3841 )

• 4 Genetic testing for Von Hippel-Lindau disease ( S3842 )

• 5 DNA analysis of the connexin 26 gene (GJB2) for susceptibility to congenital, profound deafness ( S3844 )

• 6 Genetic testing for alpha-thalassemia ( S3845 )

• 7 Genetic testing for hemoglobin E beta-thalassemia ( S3846 )

• 8 Genetic testing for niemann-pick disease ( S3849 )

• 9 Genetic testing for sickle cell anemia ( S3850 )

• 10 Genetic testing for myotonic muscular dystrophy ( S3853 )

• 11 Gene expression profiling panel for use in the management of breast cancer treatment ( S3854 )

• 12 Genetic testing, sodium channel, voltage-gated, type V, alpha subunit (SCN5A) and variants for suspected brugada syndrome ( S3861 )

• 13 Comprehensive gene sequence analysis for hypertrophic cardiomyopathy ( S3865 )

• 14 Genetic analysis for a specific gene mutation for hypertrophic cardiomyopathy (HCM) in an individual with a known HCM mutation in the family ( S3866 )

• 15 Comparative genomic hybridization (CGH) microarray testing for developmental delay, autism spectrum disorder and/or intellectual disability ( S3870 )

• 16 DNA analysis for APOE epsilon 4 allele for susceptibility to alzheimer's disease ( S3852 )